Impact of the patient population on the risk for heparin-induced thrombocytopenia

Blood - Tập 96 Số 5 - Trang 1703-1708 - 2000
Theodore E. Warkentin1, Jo‐Ann I. Sheppard1, Peter Horsewood1, Patricia J. Simpson1, Jane C. Moore1, John G. Kelton1
1From the Department of Pathology and Molecular Medicine and the Department of Medicine, McMaster University; and from the Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada.

Tóm tắt

Abstract The frequency of immune heparin-induced thrombocytopenia (HIT) varies among prospective studies. It is unknown whether this is caused by differences in the heparin preparations, the patient populations, or the types of serologic assay used to confirm the diagnosis. Seven hundred forty-four patients were studied from 3 different clinical treatment settings, as follows: unfractionated heparin (UFH) during or after cardiac surgery (n = 100), UFH after orthopedic surgery (n = 205), and low-molecular-weight heparin (LMWH) after orthopedic surgery (n = 439). Both an activation assay and an antigen assay were used to detect heparin-dependent IgG (HIT-IgG) antibodies. By activation assay, the frequency of HIT-IgG formation ranged from a low of 3.2% in orthopedic patients receiving LMWH to a high of 20% in cardiac patients receiving UFH; by antigen assay, the corresponding frequencies ranged from 7.5% to 50%. Both UFH use (P = .002) and cardiac surgery (P = .01) were more likely to be associated with HIT-IgG formation. However, among patients in whom HIT-IgG formed and who were administered UFH, the probability for HIT was higher among orthopedic patients than among cardiac patients (by activation assay: 52.6% compared with 5%; odds ratio, 21.1 [95% CI, 2.2-962.8]; P = .001; by antigen assay: 34.5% compared with 2.0%; odds ratio, 25.8 [95% CI, 3.2-1141]; P < .001). It is concluded that there is an unexpected dissociation between the frequency of HIT-IgG formation and the risk for HIT that is dependent on the patient population. HIT-IgG antibodies are more likely to form in patients who undergo cardiac surgery than in orthopedic patients, but among patients in whom antibodies do form, orthopedic patients are more likely to develop HIT.

Từ khóa


Tài liệu tham khảo

Babcock, 1976, Heparin-induced immune thrombocytopenia., N Engl J Med., 295, 237, 10.1056/NEJM197607292950501

Chong, 1982, Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation., Lancet., 2, 1246, 10.1016/S0140-6736(82)90106-4

Kelton, 1988, Heparin-induced thrombocytopenia: laboratory studies., Blood., 72, 925, 10.1182/blood.V72.3.925.bloodjournal723925

Amiral, 1992, Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin induced thrombocytopenia [letter]., Thromb Haemost., 68, 95, 10.1055/s-0038-1656329

Greinacher, 1994, Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen., Thromb Haemost., 71, 247

Kelton, 1994, Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4., Blood., 83, 3232, 10.1182/blood.V83.11.3232.3232

Visentin, 1994, Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells., J Clin Invest., 93, 81, 10.1172/JCI116987

Schmitt, 1993, Heparin-induced thrombocytopenia: a critical review and pooled analysis., Am J Med Sci., 305, 208, 10.1097/00000441-199304000-00003

Warkentin, 1995, Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin., N Engl J Med., 332, 1330, 10.1056/NEJM199505183322003

Sheridan, 1986, A diagnostic test for heparin-induced thrombocytopenia., Blood., 67, 27, 10.1182/blood.V67.1.27.27

Warkentin, 1992, Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia., J Lab Clin Med., 120, 371

Greinacher, 1991, A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia., Thromb Haemost., 66, 734, 10.1055/s-0038-1646493

Greinacher, 1994, Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay., Transfusion., 34, 381, 10.1046/j.1537-2995.1994.34594249047.x

Horsewood, 1996, The epitope specificity of heparin-induced thrombocytopenia., Br J Haematol., 95, 161, 10.1046/j.1365-2141.1996.d01-1876.x

Arepally, 1995, Comparison of PF4/heparin ELISA assay with 14C-serotonin release assay in the diagnosis of heparin induced thrombocytopenia., Am J Clin Pathol., 104, 648, 10.1093/ajcp/104.6.648

Nguyên, 1995, Comparison between platelet factor 4/heparin complexes and platelet aggregation test in heparin-induced thrombocytopenia [letter]., Thromb Haemost., 74, 804, 10.1055/s-0038-1649823

Look, 1997, Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis., Am J Clin Pathol., 108, 78, 10.1093/ajcp/108.1.78

Levine, 1991, Prevention of deep vein thrombosis after elective hip surgery: a randomized trial comparing low molecular weight heparin with standard unfractionated heparin., Ann Intern Med., 114, 545, 10.7326/0003-4819-114-7-545

Warkentin, 1995, Formation of heparin-induced thrombocytopenia IgG without thrombocytopenia: analysis of a clinical trial [abstract]., Blood., 86(suppl 1), 537

Matthews, 1988, Using and Understanding Medical Statistics., 2nd ed., 20

Thomas, 1971, Exact confidence limits for the odds ratio in a 2 × 2 table., Appl Stat., 20, 105, 10.2307/2346643

Visentin, 1996, Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes., J Clin Lab Med., 128, 376, 10.1016/S0022-2143(96)80009-6

Bauer, 1997, Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery., Circulation., 95, 1242, 10.1161/01.CIR.95.5.1242

Trossaërt, 1998, High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery., Br J Haematol., 101, 653, 10.1046/j.1365-2141.1998.00750.x

Cella, 1981, The release of beta-thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery., Eur J Clin Invest., 11, 165, 10.1111/j.1365-2362.1981.tb01836.x

Zilla, 1987, PGI2 and PGE1 induce morphological alterations in human platelets similar to those of the initial phase of activation., Exp Hematol., 15, 741

Amiral, 1996, Presence of auto-antibodies to interleukin-8 or neutrophil activating peptide-2 in patients with heparin-associated thrombocytopenia., Blood., 88, 410, 10.1182/blood.V88.2.410.bloodjournal882410

Pouplard, 1999, Affinity purification of different heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation [abstract]., Blood., 94(suppl 1), 16

Ginsberg, 1995, Antiphospholipid antibodies and venous thromboembolism., Blood., 86, 3685, 10.1182/blood.V86.10.3685.bloodjournal86103685

Thông tin
Thông tin xuất bản

Blood

Tập 96 Số 5

1703-1708

Thông tin tác giả